Literature DB >> 27275113

Diagnosis of Genus Helicobacter through a hemi-nested PCR assay of 16S rRNA.

Heping Qin1, Guodu Tang1, Ping Yi2, Xinyi Pan3, Huali Huang1, Renjie Chang1, Zhe Shi4, Muhammad Aqeel Ashraf5.   

Abstract

The present study aimed to establish a genus-specific PCR-based assay to detect helicobacters using 16S rRNA gene as the target template. We designed the hemi-nested primers based on sequences of 16S rRNA gene of 34 types of Helicobacter species. The inclusivity, sensitivity, and specificity of the PCR assay using these primers were examined in three different models, comprising feces simulated samples, BLAB/c mice infection model and clinic patients samples. The detection sensitivity of Helicobacter pylori, Helicobacter hepaticus and Helicobacter bilis strains from feces simulated samples was all 102 CFU/ml. We successfully detected H. hepaticus and H. bilis in the liver, cecum and feces of experimentally infected mice. H. pylori was successfully detected in the feces samples from 3 patients infected with H. pylori while not in the feces samples from 3 healthy human. However, the C97/C05-C97/C98 PCR assay detected H. pylori in the 2 positive samples. Due to the PCR assay's excellent inclusivity, high sensitivity and specificity it may be used to detect the presence of Helicobacters.

Entities:  

Keywords:  16S rRNA; Helicobacter; Hemi-nested PCR assay

Year:  2016        PMID: 27275113      PMCID: PMC4881236          DOI: 10.1016/j.jsps.2016.04.015

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


Introduction

A large number of studies confirmed that Helicobacter spp. have their share in the pathogenesis of diseases of the digestive system, ever since Helicobacter pylori was first recognized as an important factor in the genesis of gastritis, peptic ulcer and gastric adenocarcinoma in human (Parsonnet et al., 1991, Dunn et al., 1997). The number of Helicobacter spp. identified is increasing as more research is done in this field. With 34 Helicobacter species now formally named according to LPSN (http://www.bacterio.net/h/helicobacter.html), it is clear that Helicobacter species can infect human and various animal hosts, as well as colonize different anatomical regions of the gastrointestinal system (Fox, 2002, Recordati et al., 2009). Culture of helicobacter organisms can be used to identify infected hosts. However, the bacteria are fastidious and initial in vitro isolation therefore requires special microaerophilic conditions and 5–7 days (Fox et al., 1994, Fox et al., 1995). Detection of helicobacters by culture is further complicated by the presence of normal flora, since the preferred site for isolation of the bacteria is the gastrointestinal tract. In addition to culture, the immunological assays are also important techniques. However, the difficulties to culture many fastidious Helicobacter species to obtain enough cells for the extraction of cell surface proteins are still a challenge. Therefore there is a need to develop an easy to use and reliable assay to detect and discriminate helicobacters (Wadstrom et al., 2009). The association between the Helicobacter spp. and gastrointestinal diseases can also be determined by proving the presence of the Helicobacter spp. DNA in samples that are collected during the examinations. The procedure became simpler and more precise, which allowed an evolution of PCR in the sense of being more feasible, but also a sophisticated and reliable method that has proven its usefulness in dealing with the association. (Engstrand et al., 1992, Lin et al., 1995, Fox et al., 1998, Myung et al., 2000, Monstein et al., 2002). However, Poynter et al. reported that three out of six different commercial laboratories performing helicobacter testing on the same spiked fecal samples failed to detect and identify Helicobacter hepaticus due to the differences in the design of their PCR assays (Poynter et al., 2009). Bulajic et al. concluded that further investigation of Helicobacter spp. role in the development of malignancies and other diseases requires targeting of new genome sequences or design of more specific primers (Bulajic et al., 2012). The PCR subtypes used included nested PCR and single-round PCR. Nested PCR has been used frequently in recent years due to its higher specificity. The most sensitive and widely used method for detecting helicobacter infections is PCR targeting at a genus-specific and conserved region of 16S rRNA (Battles et al., 1995, Bulajic et al., 2012). In this study, we have tried to establish and optimize a hemi-nested PCR assay that would simultaneously detect and differentiate 34 of the formally named helicobacters from feces samples. The primers were designed based on the sequences of 16S rRNA.

Materials and methods

Strains and culture

H. pylori (ATCC43504), H. hepaticus (ATCC51448), Helicobacter bilis (ATCC43879) were obtained from the department of Gastroenterology in NanFang Hospital. H. pylori were cultured on Brucella agar. H. hepaticus, H. bilis and Campylobacter jejuni were cultured on selective C. jejuni agar (containing 10 mg/L vancomycin, 5 mg/L trimethoprim, and 2500 U/L polymyxin B), supplemented with 5–10% sterile defibrinated sheep blood. Plates were incubated for 3–7 days under microaerobic conditions at 37 °C at high humidity in microaerobic chamber (10%CO2, 5%O2, and 85%N2). Escherichia coli, and Enterococcus faecalis were cultured in Columbia agar at 37 °C.

Genomic DNA extraction

Bacteria were cultured on plates and the cells were harvested and washed twice with 1 ml of PBS. Bacteria genomic DNA extraction was performed using Qiagen RNA/DNA Mini Kit (Qiagen Inc.) according to the manufacturer’s instructions.

DNA extraction from feces and tissue

DNA was extracted from 220 mg of fecal and tissue specimen using the QIAamp DNA Mini stool Kit (Qiagen Inc.) according to the manufacturer’s instructions. DNA content and purity were determined spectrophotometrically by measuring the A260/A280 optical density ratio.

The primers were analyzed using DNAMAN 8.0 and OLIGOU 7.0

PCR amplification

The hemi-nested universal Primers were designed with Primer Premier 6.0 on the basis of nucleotide sequence of 16S rRNA of all 34 type strains. Primary reactions used 1.0 μl of purified bacteria DNA (1 ng), or 5.0 μl of serially diluted suspensions of bacteria spiked stool DNA (25–100 ng) as the template in a total volume of 50 μl, unless otherwise stated. In the first amplification step Genomic DNA was amplified in a total volume of 50 μl containing PCR buffer (1X), 200 μM dNTP, 1.5 mM Mg2+, 0.2 mM primers (outer-F: 5′ CTGGCGGCGTGCCTAATAC 3′ and outer-R: 5′ CTCACGACACGAGCT GAC 3′) and 1.5 U Taq DNA polymerase (TaKaRa, Japan). The reaction mixture was initially denatured for 3 min at 94 °C, then amplified for 30 cycles as follows: denaturation for 30 s at 94 °C, primer annealing for 30 s at 58 °C and extension for 30 s at 72 °C. A final extension step was done for 5 min at 72 °C (Thermocycler ABI 9700). An amplification product of 1000 bp by the outer primers was expected. In the second amplification step PCR was repeated as above with minor alterations: 1.0 μl of amplicon (the first step PCR products diluted 100-fold) was used for the second amplification step, primer annealing for 50 s at 58 °C, and inner-F (5′ CTGGCG GCGTGCCTAA TAC 3′)/inner-R (5′ ACCCTCTCAGGCC GGATACC 3′) primers were used. The expected size of the amplicon was 250 bp or 430 bp. PCR product sequencing was performed by BGI Corporation with helicobacter (inner-F and inner-R) sequencing primers (Table 1). The sequences were determined by means of an automatic sequencer (3730XL; Applied Biosystems), the dye terminator reaction (Bigdye V3.1 Mix kit). For quality control, each DNA extraction and PCR amplification run included a positive control and negative control (double distilled water instead of sample). All PCR assays were performed in triplicate on three separate occasions.
Table 1

Comparison of the hemi-nested primers used in this study and other universal primers.

ReferencesSequenceInclusiveaEvaluationb
Avenaud et al. (2000)ForwardHS1: 5′ AACGATGAAGCTTCTAGCTTGCTAG 3′83′-end dimer between the primers
ReverseHS2: 5′ GTGCTTATTCGTTAGATACCGTCAT 3′



Coppola et al. (2002)Forward5′ ACGATGAAGCTTCTAGCTTGCTAG 3′93′-end Forward Primer dimer
Reverse5′ TGCTTATTCGTTAGATACCGTCAT 3′



Huang et al. (2004)Forward5′ GTCATGACGGGTATCC 3′21High difference between (F/R) product and primer melting temperatures
Reverse5′ ACTTCACCCCAGTCGCTG 3′



Fukuda et al. (2002)Forward5′ GCTATGACGGGTATCC 3′30High difference between (F/R) product and primer melting temperatures
Reverse5′ GATTTTACCCCTACACCA 3′



Nilsson et al. (2006)Outer forward5′ CTATGACGGGTATCCGGC 3′31High difference between (F/R) product and primer melting temperaturesHigh difference between (U/L) product and oligo melting temperaturesTerminal stability of the Forward Primer is too highTerminal stability of the Upper Oligo is too high
Outer reverse5′ CTCACGACACGAGCTGAC 3′
Inner forward5′ CTATGACGGGTATCCGGC 3′
Inner reverse5′ TCGCCTTCGCAATGAGTATT 3′



Bohr et al. (2004)Forward5_-GCTATGACGGGTATCC-3_31High difference between (F/R) product and primer melting temperatures
Reverse5_-TCGCAATGAGTATTCCTCTT-3



Rocha et al. (2005a)ForwardC96: 5′ ACGGGTGAGTAACGCATAGG 3′10High difference between (F/R) product and primer melting temperatures
ReverseR4-16SCHPEC: 5′ CCTACGGTTACCTT GTT ACGAC 3′



Fox et al. (1998)Outer forwardC97: 5′ GCTATGACGGGTATCC3′25High difference between (F/R) product and primer melting temperatures
Outer reverseC05: 5′ ACTTCACCCCAGTCGCTG 3′
Inner forwardC97: 5′ GCTATGACGGGTATCC 3′
Inner reverseC98: 5′ GATTTTACCCCTACACCA 3′



Pellicano et al. (2004)Outer forward5′ ATTAGTGGCGCACGGGTGAGTAA 3′6High difference between (F/R) product and primer melting temperaturesHigh difference between (U/L) product and oligo melting temperatures3′-end dimer between the Forward and Reverse primers3′-end dimer between the Upper and Lower oligos
Outer reverse5′ TTTAGCATCCCGACTTAAGGC 3′
Inner forward5′ GAACCTTACCTAGGCTTGACATTG 3′
Inner reverse5′ GGTGAGTACAAGACCCGGGAA 3′



Goto et al. (2000)Forward5′ CTA TGACGG GTA TCC GGC 3′31High difference between (F/R) product and primer melting temperaturesTerminal stability of the Forward Primer is too high
Reverse5′ CTC ACGACA CGA GCT GAC 3′



Riley et al. (1996)ForwardH276f: 5′ CTATGACGGGTATCCGGC 3′29Terminal stability of the Upper Primer is too highExcessive difference between product and primer melting temperatures
ReverseH676: 5′ ATTCCACCTACCTCTCCCA 3′



This studyOuter forward5′ CTGGCGGCGTGCCTAATAC 3′34None
Outer reverse5′ CTCACGACACGAGCTGAC 3′
Inner forward5′ CTGGCGGCGTGCCTAATAC 3′
Inner reverse5′ ACCCTCTCAGGCCGGATACC 3′

Numbers in the fourth column indicate the number of helicobacters totally matched with the primer.

The primers were analyzed by OLIGOU7.0 on the basis of H. pylori 16S rRNA.

Assay specificity

The specificity of the primers was tested under the above-mentioned conditions as well as with DNAs extracted from C. jejuni, E. coli, and E. faecalis.

Assay sensitivity

To investigate the sensitivity of the primers in the setting of abundant genomic DNA of enteric bacteria, the nested PCR was performed using DNA extracted from fecal samples of a healthy human uninfected with H. pylori, H. hepaticus and H. bilis. The fecal samples were spiked with serially diluted suspensions of H. pylori, H. hepaticus and H. bilis. In some experiments, 10-fold dilutions (10, 102, 103, 104, 105, and, 106 CFU) of a known stock concentration of three helicobacters suspended in PBS were spiked into 200 mg fecal samples before DNA extraction.

Animal infection model and sample collection

Specific pathogen-free BLAB/c mice were purchased at 6–7 weeks of age from Nanfang University. To determine whether BLAB/c mice were free of H. hepaticus and H. bilis or not, we used our assay and conventional method (Fox et al., 1998, Rocha et al., 2005a). For mouse inoculation, H. hepaticus and H. bilis were adjusted to 107–9 CFU/200 μl. Three mice were infected with 200 μl of one of the cultures by intragastric gavage. Once infection was established (1 and 6 weeks after inoculation), and confirmed by fecal PCR, the mice were sacrificed. Feces, liver and cecum samples were collected to evaluate the nested-PCR assay (Jeong et al., 2011). All procedures were approved by the Institute Animal Care and Use Committee of Nanfang Medical University.

Ethical compliance

The procedure for obtaining specimens from humans in this study complied with those recommended by the Regional Ethical Committee on Human Experimentation of Liuzhou People’s Hospital. Written informed consent was obtained from each subject.

Patient

A healthy human was considered to be uninfected by H. pylori if no H. pylori was detected in the immunochemical staining followed by gastroscopic biopsy specimens and rapid urease test was negative. To determine whether healthy human were free of H. hepaticus and H. bilis or not, we used our assay and conventional method. This study included 5 patients with H. pylori infection and 5 healthy human without H. pylori infection. The feces samples from 5 patients with H. pylori infection and 5 healthy human regularly examined in a hospital in Liuzhou City were collected in September 2014. Samples were kept on ice during transfer to the Department of Microbiology, Liuzhou People’s Hospital, and were tested as soon as possible. Neither patient nor healthy human has used following medications: H2 histamine blockers, antimicrobials, proton pump inhibitors and bismuth salts within the previous four weeks before samples were collected.

Results

The nested PCR primers were designed to the target 16S rRNA gene specific to all 34 type strains of Helicobacter spp., not including any rare bases. Theoretically, the primers, being able to detect all the type strains, have not any faults according to the Oligo7.0 Software evaluation. In comparison with it, not only the inclusivity but also some faults lies in other primers usually used in the literature, as described in Table 1. Furthermore, the expected products size and optimal annealing temperature to 34 type strains were described in Table 2. Numbers in the sixth column indicate the positions of the primers to different type strains. The optimal annealing temperature fluctuates from 55.3 °C to 57.8 °C for the inner primers, and from 56.5 °C to 57.9 °C for the outer primers (Table 2). In practice, the excellent validity of the method was examined by feces simulated samples (Fig. 2), BLAB/c mice infection models (Fig. 3) and H. pylori infection fecal samples (Fig. 4).
Table 2

The location and optimal annealing temperature of the primers in 34 type strains of Helicobacter spp.a

TaxonType strain16S rRNA accession NO.LocationOptimal annealing temperatureb (°C)
Helicobacter acinonychisH. strain 90-119/ATCC51101M8814836/270/103157.5/57.1
Helicobacter anserisH. strain MIT 04-9362/ATCC BAA-1299DQ41554528/261/102057.5/57.4
Helicobacter auratiH. strain MIT 97-5075c/ATCC BAA-1AF29786828/261-101756.7/57.6
Helicobacter baculiformisH. strain M50 /CCUG 53816/LMG 23839EF07034228/259/101057.1/57.9
Helicobacter bilisH. strain Hb1/ATCC 51630U1876628/441/119956.5/57.2
Helicobacter bizzozeroniiH. strain Hänninen 1/Storkis/CCUG 35545Y094049/240/100056.9/57.8
Helicobacter brantaeH. strain MIT 04-9366/ATCC BAA-1298DQ41554628/263/102157.4/57.7
Helicobacter canadensisH. strain NLEP-16143/ATCC 700968AF26203713/246/100357.3/57.3
Helicobacter canisH. strain ATCC 51401AY63194528/261/102057.2/57.6
Helicobacter cetorumH. strain MIT 99-5656/ATCC BAA-540AF29237828/262/102356.9/57.6
Helicobacter cholecystusH. strain Hkb-1/ATCC 700242AY68660628/261/101957.5/57.9
Helicobacter cinaediH. strain Fennell 165/CCUG 18818M8815028/262/102057.4/57.7
Helicobacter cynogastricusH. strain JKM4/LMG 23188DQ00468928/259/102457.0/57.7
Helicobacter equorumH. strain EqF1/CCUG 52199DQ30773526/259/101757.2/57.7
Helicobacter felisH. strain CS1/ATCC 49179M5739828/259/102057.2/57.8
Helicobacter fennelliaeH. strain Fennell 231/ATCC 35684M8815436/622/103855.3/56.5
Helicobacter ganmaniH. strain CMRI H02/CCUG 43526/CIP 106846AF0002219/240/99856.8/57.4
Helicobacter heilmanniiStrain ASB1 = DSM 24751HM62582036/267/102857.0/57.8
Helicobacter hepaticusH. strain Hh-2/ATCC 51448U0757428/261/101757.3/57.7
Helicobacter macacaeMIT 99-5501 = LMG 26486AF33333872/470/122756.0/56.9
Helicobacter marmotaeH. strain MIT 98-6070/ATCC BAA-546AF33334128/261/101857.2/57.5
Helicobacter mastomyrinusH. strain MIT 97-5574/ATCC BAA-1046AY74230728/550/130756.2/57.0
Helicobacter mesocricetorumH. strain MU 97-1514/ATCC 700932AF07247112/245/100356.7/57.3
Helicobacter muridarumH. strain ST1/ATCC 49282M8020533/266/102457.3/57.6
Helicobacter mustelaeH. strain R85-13-6/ATCC 43772M3504836/269/102857.8/57.6
Helicobacter nemestrinaeH. strain T81213-NTB/ATCC 49396X6785436/266/102756.8/56.7
Helicobacter pametensisH. strain Seymour B9/ATCC 51478M8814735/270/102857.5/57.7
Helicobacter pullorumH. strain ATCC 51801/CCUG 33837AY63195629/262/102057.6/57.8
Helicobacter pyloriH. strain Royal Perth Hospital 13487/ATCC 43504U0133036/271/103257.1/57.6
Helicobacter rodentiumH. strain MIT 95-1707/ATCC 700285U9629613/244/100257.2/57.6
Helicobacter salomonisH. strain Inkinen/CCUG 37845/CIP 105607U8935113/244/100557.1/57.8
Helicobacter suisH. strain HS1/DSM 19735EF20458918/249/101056.5/57.7
Helicobacter trogontumH. strain LRB 8581/ATCC 700114U6510313/246/100257.5/57.8
Helicobacter typhloniusH. strain MIT 97-6810/ATCC BAA-367AF12791213/405/116155.8/57.1

The location and optimal annealing temperature for the hemi-nested primers were determined by OLIGOU7.0.

The former temperature is for the inner primers, and the latter is for outer primers.

Figure 2

Ethidium bromide-stained agarose gel showing products resulting from amplification of DNA from various bacteria. LaneM, markers (Omega Marker DL-2000); lane 1, H. pylori; lane 2, H. hepaticus; lane 3, H. bilis; lane 4, E. coli; lane 5, C. jejuni; lane 6, E. faecalis; lane7, B. fragilis; lane 8, P. aeruginosa; lane 9, S. aureu;. Lane 10, negative control.

Figure 3

Sensitivity of detection of H. pylori (A), H. hepaticus (B) and H. bilis (C)-specific 16S rRNA gene by the nested PCR. Tenfold dilutions of pure bacterial culture were spiked into healthy human stool, and nested PCR was performed by using the extracted DNA from contaminate stool. LaneM, markers (Omega Marker DL-2000); PC, positive control; NC, negative control; lane 1, 106 CFU; lane 2, 105 CFU; lane 3, 104 CFU; lane 4, 103 CFU; lane 5, 102 CFU; lane 6, 10 CFU; lane 7, 1 CFU.

Figure 4

Nested PCR with experimental samples collected from H. hepaticus infected mice (A and B). Nested PCR amplification of DNA extracted from feces samples from 3 uninfected control (lane 1–3 in A) and 3 infected mice (lane 4–6 in A). Nested PCR amplification of DNA extracted from liver (lane 1–3 in B) and cecum samples (lane 4–6 in B) from 3 infected mice. Nested PCR with experimental samples collected from H. bilis infected mice (C and D). Nested PCR amplification of DNA extracted from feces samples from 3 uninfected control (lane 1–3 in C) and 3 infected mice (lane 4–6 in C). Nested PCR amplification of DNA extracted from liver (lane 1–3 in D) and cecum samples (lane 4–6 in D) from 3 infected mice. LaneM, markers (Omega Marker DL-2000); PC, positive control; NC, negative control.

DNAs extracted from H. pylori, H. hepaticus and H. bilis gave, respectively, a single amplification product of 997 bp, 990 bp and 1172 bp after the first-round PCR (Fig. 1).
Figure 1

First PCR amplification of the 16S rRNA gene of H. pylori, H. hepaticus and H. bilis. LaneM, markers (Omega Marker DL-2000); NC, negative control; lane 1, H. pylori; lane 2, H. hepaticus; lane 3, H. bilis.

Specificity of the genus-specific primer set was determined by amplifying DNAs prepared from the control strains. The expected DNA fragment was amplified from DNAs from the Helicobacter spp. tested (Fig. 2). Template DNAs from other bacterial genera commonly found in the human intestine were also evaluated for PCR amplification with the Helicobacter genus-specific primers. A product of the expected size was not observed with DNA from E. coli, C. jejuni, E. faecalis, Bacteroides fragilis, Pseudomonas aeruginosa, Staphylococcus aureus and negative control. The clinical detection limits determined by spiking knowing amount of H. pylori, H. hepaticus and H. bilis into healthy human fecal sample, were all 10 CFU/100 μl (Fig. 3), as previously described (Moyaert et al., 2008). Nested PCR analysis was performed on liver, cecum and feces samples obtained from infected mice after intragastric administration of H. hepaticus and H. bilis. Nested PCR using DNA extracted from the feces of three mice before H. hepaticus infection produced no amplification signal whereas single amplification signal was observed using DNA extracted after H. hepaticus infection (Fig. 4A). DNA from liver and cecum samples from 3 H. hepaticus infection mice showed the 233-bp product except for one mouse’ liver sample (Fig. 4B). DNA from feces samples collected before H. bilis infection did not show the 413-bp product with the nested PCR whereas the 413-bp product was observed after infection (Fig. 4C). DNA from liver and cecum samples from H. bilis infected mice all showed specific amplification with the nested PCR except for two liver samples (Fig.4D).

Discussion

DNAs extracted from three feces samples from patients infected with H. pylori gave a single amplification product after our PCR but DNAs from two positive samples gave a single amplification product after C97/C05–C97/C98 PCR. Our PCR produced no amplification when DNAs obtained from feces samples of healthy human were used as template. Both C97/C98 PCR and C97/C05 PCR can’t detect H. pylori in the positive fecal samples (Fig. 5B).
Figure 5

Nested PCR amplification of DNA extracted from feces samples from patients infected with H. pylori and uninfected control. (A) Left, gastric membrane from H. pylori infection patient. Right, gastric membrane from H. pylori non-infection patient (200x, Immunohistochemical staining). (B) LaneM, markers (Omega Marker DL-2000); lane 1–3, positive samples PCR using our primers; lane 4–6, positive samples PCR using C97/C05–C97/C98 primers; lane 7–9, negative samples PCR using our primers; lane 10–12, positive samples PCR using C97/C98 primers; lane 13–15, positive samples PCR using C97/C05 primers.

Molecular diagnostic methods using the polymerase chain reaction (PCR) are the gold standard in Helicobacter diagnostics. Most methods rely on the amplification of a section of the 16S rRNA gene. Therefore, the validity and accuracy of results depend heavily on the PCR design and the time of its publication because new sequences are continually being submitted to databases. Other target genes were also used as PCR target such as cdtB, vacA, glmM, glm, cagA, rps4, and 26 kDa’s port. Many studies in the past years have been always trying to find an excellent assay in inclusivity, sensitivity and specificity. The key to breakthrough is primers design. C97/C05–C97/C98 PCR cannot detect all positive H. pylori samples for primers itself. Another, multiple PCR is also very important. Regular PCR is difficult to detect helicobacter in fecal samples. Multiple PCR is more effective than regular PCR. In this report, we describe a hemi-nested PCR assay, which has excellent primers designed without any faults, for the detection of all species of helicobacter organisms formally named by LPSN. Actually, more faults lie in the primers designed for multiple PCR. In view of it, our primers are more valuable. Besides, inspection of the 16S rRNA gene sequences from all 34 type strains revealed a 100% match with our Helicobacter genus-specific oligonucleotide primers. Thus, in retrospect, successful amplification of DNA from all helicobacter species DNA with these primers is expected. It is known that PCR assays that function very specifically by using specific DNA samples as the template may not work properly when more complex DNA samples are studied (Bohr et al., 2002). We suspected that any fault of primers designed, even a base mismatch, may be amplified in the complex DNA samples. HS1/HS2 assay can detect more than 8 types of helicobacters using the purified DNA extracts as the template though it cannot totally match helicobacters 16S rRNA. Where applicable, the assay performed suboptimally on inclusivity. The investigators chose to include DNA extracts from other bacteria commonly found in the gastric and/or intestinal flora to evaluate the specificity of their assays. Moyaert et al. showed difficulties to accurately discriminate closely related taxa (Moyaert et al., 2008). Therefore, in our study, additional DNA extracts from feces of human uninfected with H. pylori, H. hepaticus and H. bilis were used to test assay specificity. No non-specific amplification was found. The assay sensitivity reached 10 bacterial cells per reaction mixture. The capability of the PCR assay was further tested by detection of H. hepaticus and H. bilis from samples obtained from infected mice, including liver, cecum and feces. Both bacteria were successfully identified. Moreover, we also evaluated the capability of the PCR assay by testing feces from patients infected with H. pylori. H. pylori was successfully identified in the feces of all infected patients. In this study, we found H. pylori test in fecal samples is more difficult than H. hepaticus and H. bilis. We guessed that fecal test is more sensitive for enterohepatic helicobacters than gastric helicobacters for the colonized location. Enterohepatic helicobacters DNA in fecal sample is more than gastric helicobacters. It was found that frozen fecal sample from H. pylori infection patients is apt to false negative results. We found that the H. pylori DNA in process of thawing may be partly destroyed. For more accurate results, we use the fresh fecal samples when testing H. pylori.

Conclusion

In our study, it was demonstrated that the hemi-nested PCR assay is highly reliable and sensitive for the genus-level identification of Helicobacter spp. This assay is able to detect all the currently known species of helicobacter and identify different species of helicobacter. Therefore, it can serve as a powerful tool for the diagnosis of the helicobacter infections.
  28 in total

1.  Absence of Helicobacter spp in the liver of patients with primary or metastatic liver cancer.

Authors:  Nicola Coppola; Giorgio De Stefano; Cecilia Marrocco; Ferdinando Scarano; Carlo Scolastico; Luciano Tarantino; Felice Piccinino; Evangelista Sagnelli; Antonio Giorgio; Pietro Filippini
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Current status of Helicobacter contamination of laboratory mice, rats, gerbils, and house musk shrews in Japan.

Authors:  K Goto; H Ohashi; A Takakura; T Itoh
Journal:  Curr Microbiol       Date:  2000-09       Impact factor: 2.188

3.  Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis.

Authors:  S J Myung; M H Kim; K N Shim; Y S Kim; E O Kim; H J Kim; E T Park; K S Yoo; B C Lim; D W Seo; S K Lee; Y I Min; J Y Kim
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.

Authors:  P Avenaud; A Marais; L Monteiro; B Le Bail; P Bioulac Sage; C Balabaud; F Mégraud
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

5.  Identification of murine helicobacters by PCR and restriction enzyme analyses.

Authors:  L K Riley; C L Franklin; R R Hook; C Besch-Williford
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Immunoblot analysis as an alternative method to diagnose enterohepatic Helicobacter infections.

Authors:  Torkel Wadström; Jann Hau; Ingrid Nilsson; Asa Ljungh
Journal:  Helicobacter       Date:  2009-06       Impact factor: 5.753

7.  Spatial distribution of Helicobacter spp. in the gastrointestinal tract of dogs.

Authors:  Camilla Recordati; Valentina Gualdi; Melanie Craven; Lorenza Sala; Mario Luini; Anna Lanzoni; Mark Rishniw; Kenneth W Simpson; Eugenio Scanziani
Journal:  Helicobacter       Date:  2009-06       Impact factor: 5.753

8.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  Detection and partial sequence analysis of Helicobacter pylori DNA in the bile samples.

Authors:  T T Lin; C T Yeh; C S Wu; Y F Liaw
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

10.  Difficulties in the molecular diagnosis of Helicobacter rodent infections.

Authors:  Scott Poynter; Julian D Phipps; Angel Naranjo-Pino; Jose M Sanchez-Morgado
Journal:  Vet Microbiol       Date:  2008-08-22       Impact factor: 3.293

View more
  3 in total

1.  The validity evaluation of different 16srRNA gene primers for helicobacter detection urgently requesting to design new specific primers.

Authors:  Shaymaa Abdelmalek; Karim Shokry; Wafy Hamed; Mohammed Abdelnaser; Ashraf Aboubakr; Sameh Abou Elenin; Mohamed Ali; Mohamed Mostafa; Mahmoud Abou-Okada
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

2.  Helicobacter hepaticus Induce Colitis in Male IL-10-/- Mice Dependent by Cytolethal Distending Toxin B and via the Activation of Jak/Stat Signaling Pathway.

Authors:  Liqi Zhu; Chen Zhu; Shuyang Cao; Quan Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-03-12       Impact factor: 5.293

3.  The Deletion of IL-17A Enhances Helicobacter hepaticus Colonization and Triggers Colitis.

Authors:  Liqi Zhu; Zhihao Wu; Chen Zhu; Jun Yin; Yuzheng Huang; Jie Feng; Quan Zhang
Journal:  J Inflamm Res       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.